The U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers recommending that health care providers, laboratory personnel, and facilities stop using the Quidel Triage Cardiac Panel, manufactured by Quidel Cardiovascular Inc. (QuidelOrtho), and use an alternative method, or an alternate local testing site if available.
Quidel Cardiovascular is recalling its Quidel Triage Cardiac Panels for risk of false negative troponin results that could cause delayed diagnosis or missed myocardial infarction